- Modafresh vs. Other Modafinil Options: In‑Depth Comparison Oct 10, 2025
- Methadone and QT-Prolonging Drugs: Understanding the Additive Arrhythmia Risk Oct 28, 2025
- 180-Day Exclusivity: How Patent Law Blocks Generic Drug Entry Mar 4, 2026
- Brinzolamide and Dry Eye Syndrome: What You Need to Know Nov 6, 2025
- Unlock the Power of Safed Musli: Your Organic Boost in a World of Artificial Enhancements Dec 27, 2023
Tag: Paragraph IV certification
Pharmacy
Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity
- Gareth Wycliffe
- Dec 10, 2025
The first generic drug filer gets 180 days of exclusive market rights under the Hatch-Waxman Act. This rule was meant to lower drug prices-but loopholes let companies delay competition. Here’s how it works, who benefits, and why reform is overdue.